244 related articles for article (PubMed ID: 20949535)
1. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.
Fritz S; Hackert T; Hinz U; Hartwig W; Büchler MW; Werner J
Br J Surg; 2011 Jan; 98(1):104-10. PubMed ID: 20949535
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
3. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas.
Kanno A; Satoh K; Hirota M; Hamada S; Umino J; Itoh H; Masamune A; Asakura T; Shimosegawa T
J Gastroenterol; 2010 Sep; 45(9):952-9. PubMed ID: 20383536
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
[TBL] [Abstract][Full Text] [Related]
5. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
6. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
[TBL] [Abstract][Full Text] [Related]
7. Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.
Xu B; Ding WX; Jin DY; Wang DS; Lou WH
World J Gastroenterol; 2013 Mar; 19(9):1451-7. PubMed ID: 23539521
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of tumor markers and biochemistry in the preoperative invasive assessment of intraductal papillary mucinous neoplasm of the pancreas.
You L; Ma L; Zhao WJ; Zhao YP; Dai MH
Clin Chim Acta; 2016 Feb; 454():89-93. PubMed ID: 26746574
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas.
Qian Y; Gong Y; Luo G; Liu Y; Wang R; Zou X; Deng S; Lin X; Chen Y; Wang X; Yu X; Cheng H; Liu C
World J Surg Oncol; 2022 Sep; 20(1):310. PubMed ID: 36155113
[TBL] [Abstract][Full Text] [Related]
10. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas (Br J Surg 2011; 98: 104-110).
Efe C
Br J Surg; 2012 Sep; 99(9):1315; author reply 1315-6. PubMed ID: 22864897
[No Abstract] [Full Text] [Related]
11. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.
Roch AM; Ceppa EP; Al-Haddad MA; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Ann Surg; 2014 Oct; 260(4):680-8; discussion 688-90. PubMed ID: 25203885
[TBL] [Abstract][Full Text] [Related]
12. The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms.
Zhuge X; Zhou H; Chen L; Chen H; Chen X; Guo C
BMC Cancer; 2021 Nov; 21(1):1253. PubMed ID: 34800987
[TBL] [Abstract][Full Text] [Related]
13. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula.
Hwang DW; Jang JY; Lim CS; Lee SE; Yoon YS; Ahn YJ; Han HS; Kim SW; Kim SG; Yun YK; Han SS; Park SJ; Lim TJ; Kang KJ; Sim MS; Choi SH; Heo JS; Choi DW; Hur KY; Lee DS; Yun SS; Kim HJ; Cho CK; Kim HJ; Yu HC; Cho BH; Song IS
J Korean Med Sci; 2011 Jun; 26(6):740-6. PubMed ID: 21655058
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
15. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jang JY; Park T; Lee S; Kim Y; Lee SY; Kim SW; Kim SC; Song KB; Yamamoto M; Hatori T; Hirono S; Satoi S; Fujii T; Hirano S; Hashimoto Y; Shimizu Y; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Han HS; Yoon YS; Sho M; Nagano H; Honda G; Kim SG; Yu HC; Chung JC; Nagakawa Y; Seo HI; Yamaue H
Ann Surg; 2017 Dec; 266(6):1062-1068. PubMed ID: 27607098
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
[TBL] [Abstract][Full Text] [Related]
17. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
[TBL] [Abstract][Full Text] [Related]
18. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.
Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T
J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
20. Serum tumor markers not useful in screening patients with pancreatic mucinous cystic lesions associated with malignant changes.
Pezzilli R; Calculli L; Melzi d'Eril G; Barassi A
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):553-557. PubMed ID: 27733327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
